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In this study, we investigated whether ZnO coating on Ag nanoparticles tunes electron flux and 
hole figuration at Metal-semiconductor interface under UV radiation. This effect triggers photo 
activity and generation of reactive oxygen species (ROS) from Ag@ZnO nanoparticles which 
results in enhanced cytotoxic effects and apoptotic cell death in human breast cancer cells 
(MDA-MB231). In this context, up-regulation of apoptotic cascade proteins (i.e. Bax/Bcl2 
association, p53, Cytochrome C and caspase-3) along with activation of oxidative stress 
proteins suggested occurrence of apoptosis by Ag@ZnO NPs in cancer cells through 
mitochondrial pathway. Also, pre-incubation of breast cancer cells with Ag@ZnO NPs in dark 
conditions muted NPs-related toxic effects and consequent apoptotic fate, highlighting 
biocompatible properties of un-excited Ag@ZnO NPs. Furthermore, diagnostic efficacy of 
Ag@ZnO NPs as CT/optical nano-probes was investigated. Results confirmed the efficacy of 
the photo-activated system in obtaining desirable outcomes from CT/optical imaging which, 














Application of nanotechnology in biomedical sciences is widely expected to change the 
landscape of treatment and diagnosis . While researchers are faced with tremendous challenges 
in controlling cell-nanoparticles interactions, novel metallic nanoparticles have attracted 
important attention because of their unique interactions with biological entities 1. Advances in 
development of metallic nanoparticles are being translated into more selective and effective 
treatment of cancer as well as antibacterial threats 2. Among metallic nanostructures, silver NPs 
are the most frequently used ones because of their potent properties in inducing cell death 
mechanisms 3-4. These mechanisms help nanoparticles to overcome multi drug resistance 
(MDR), resulting in improvement of treatment efficiency5. However, such nanoparticles 
address promising therapeutic candidates, whose toxic effects are not limited to the target cells.  
Over the past few years, energy transfer between quantum dots and their neighbor conjugations 
has proven to be a very useful tool in many photochemical investigations. Recent studies have 
revealed that optical properties of ZnO and silver NPs, as isolated systems, are determined by 
excitons and plasmons, respectively6. In core/shell structures, a very thin shell layer of a 
semiconductor can enhance plasmonic features of the core via plasmon-excitons coupling7. A 
direct contact between ZnO and Ag can result in interfacial processes of charge transfer which 
are the most important aspects for photocatalytic reactions. Furthermore, when an external ultra 
violet radiation interacts with these nanoparticles, they can generate radicals in the 
environment8. ROS induction in cancer cells trigger the activation of pro-apoptotic enzymes 
for development of apoptosis and cell death which is more effective in photodynamic therapy 
with localized radiation exposure9. A composite structure of silver NPs, covered by ZnO as a 
semiconductor shell, is proposed to achieve a core/shell nanoparticle with novel and special 
optical/electronic and biomedical properties. A preliminary study has demonstrated special 
properties of the Ag@TiO2 clusters to store electrons under UV-irradiation and discharge them 
in the dark 10. Another research has shown that interfacial charge exchange between the metal 
and the semiconductor has a substantial role in defining the photoactivity of the composite11. 
Furthermore, these metal@semiconductor core-shell clusters have photocatalytic activities and 
are appropriate to promote light-triggered electron-transfer reactions10. Au@ZnO core-shell 
nanoparticles have great potentials for optical-based molecular reactions which could pave the 
way for planning new optical based nanocomposites for application in chemical sensing12. 
Additionally, nano-based platforms could provide a valuable opportunity to improve dynamic 
contrast-enhanced imaging techniques for diagnosis of cancers or tracing the target cells by 
multimodal theranostic agents13. Therefore, Ag@ZnO NPs could be introduced as 
multifunctional nanoparticles for treatment of cancer (via ROS generation) while at the same 
time can be useful contrast agents for optical and computed tomography (CT-Scan) dual-mode 
imaging14. 
In this project Ag@ZnO NPs were synthesized and well characterized with transmission 
electron microscopy (TEM), UV-visible spectroscopy, X-ray diffraction (XRD) and small 
angle X-ray spectroscopy (SAXS). Also, release of Ag+ ions from Ag@ZnO NPs and bare Ag 
NPs was studied over 75 days. Breast cancer (MDA-MB231) and healthy lung fibroblast 
(MRC5) cells were treated with different concentrations of ZnO, Ag and Ag@ZnO 
nanoparticles under UV radiation to determine cytotoxic effects and apoptosis pathways. 
Furthermore, intracellular ROS generation of Ag@ZnO NPs in dark condition and under UV 
radiation was assessed, followed by evaluation of superoxide dismutase (SOD) and glutathione 
reductase (GR) enzymes as a measure of cell response to oxidative stress. Moreover, 
mechanisms of damaged caused by ROS and apoptosis pathways were assessed by 
measurement of P53, Bax/bcl2 Ratio, caspase 3 and cytochrome C. Additionally, the efficiency 
of Ag@ZnO NPs as simple and versatile contrast agent for optical/CT imaging was evaluated. 
 
Results & Discussion 
Size, Composition, Structure and Analytical Characterization of Ag@ZnO NPs 
In order to obtain an effective multifunctional nanoparticle as a novel platform with anticancer 
and imaging contrast enhancement properties, spherical Ag@ZnO NPs were synthesized. 
Figure 1 schematically illustrates the ability of the Ag@ZnO NPs to store electrons under UV-
radiation and discharge them on demand in dark. ZnO shell coated on Ag NPs, undergoes Fermi 
level equilibration and following the UV-excitation the efficiency of charge-transfer process is 
enhanced15. The photo-induced charge separation in the semiconductor shell is followed by 
electron injection into the metal core (Figure 1B). The stored electrons and more likely holes 
are transferred to an environmental electron/hole acceptor and produce radicals 16. Moreover, 
As the electrons from the metal core are discharged, the original surface plasmon absorption 
of the metal core is restored 17.  
 
Figure 1. Schematic representation of band structure of Ag/ZnO junction and Fermi energy 
level equilibrium. As fermi energy level of ZnO (Efs) is lower than that of Ag (Efm), electrons 
from Ag are transferred to ZnO until the two systems achieve equilibrium with forming a new 
Fermi energy level (Ef) (A). Schematic of proposed charge separation process and 
photocatalytic mechanism of Ag@ZnO NPs after excitation with UV radiation. Due to the 
higher energy level of ZnO conduction band than the newly formed Fermi energy level of Ef, 
the photo activated electrons are transferred to the metallic Ag at the interface. Then, the holes 
are transferred to the surface of semiconductor to catch the electron from environmental 
molecules (specifically, H2O and O2) and Produce ROS (B).  
 
Figure 2A schematically represents the main steps of producing Ag@ZnO NPs. Zn+ ions are 
adsorbed onto the surface of negatively charged citrate coated Ag NPs through electrostatic 
interactions and reacted with NaOH to allow direct formation of ZnO shell on the surface of 
Ag NP core. The synthesized NPs are calcined at 550 ̊C in order to obtain a better crystallization 
and a gradual formation of continuous ZnO shell during the annealing process 18. TEM 
(transmission electron microscopy) micrograph and corresponding size distribution analysis of 
Ag@ZnO NPs after heat treatment show spherical morphologies with an average size of 16 nm 
along with mean thickness of 3 nm for ZnO shell (Figure 2 B, C and S1). Moreover, dynamic 
light scattering (DLS) studies of the dispersed NPs showed a mean size of 30 nm and 70 nm in 
water and DMEM cell culture media, respectively (Figure S2 A and B). UV-Vis absorption 
spectra of Ag NPs (~ 15nm), ZnO NPs (~ 3nm) and Ag@ZnO (~ 18nm) NPs in the region of 
200-800 nm exhibit an absorption peak at ~ 420, 320 and 360 nm, respectively (Figure 2 D). 
absorption at 320 nm can be assigned to absorption edge of ZnO NPs, while the 420 nm can be 
attributed to the characteristic surface plasmon resonance of metallic silver 19. By means of 
electrodynamic calculations based on Mie theory for coated spheres, and applying the 
Maxwell–Garnett effective medium theory to calculate the average dielectric constant of the 
shell, it was possible to both qualitatively and quantitatively, describe the changes in the UV-
vis spectra as a consequence of the ZnO shell formation over the Ag NP 20. The powder XRD 
patterns of ZnO NPs and calcined Ag@ZnO NPs are shown in Figure 2E from which Ag@ZnO 
NPs can be identified. The diffraction peaks can be indexed to hexagonal wurtzite ZnO, 
whereby no diffraction peak from any other impurity is detected. It indicates that Ag@ZnO 
NPs have good crystal quality, with some typical and sharp peaks of ZnO at 2-theta values. 
The peaks of Ag indicate strong interfacial interactions between ZnO and Ag, which is in 
accordance with the results of TEM 21. In addition, study of the XRD pattern of Ag@Zn(OH)2 
has shown peaks corresponding to orthogonal Zn(OH)2 (Figure S3).  
The small angle X-ray scattering (SAXS) has been performed to structurally characterize the 
nanoparticles in nanometer range. The experimental scattering patterns and the corresponding 
simulated curves from Ag core and the Ag@ZnO NPs are shown in Figure 2F. We have applied 
a polydisperse hard sphere and the polydisperse core-shell model for the simulation of 
scattering curves from Ag core and the Ag@ZnO core-shell NPs, respectively. Therefore, we 
obtained a core size of 15.6 nm and the shell thickness of 3.0 nm. It is worth to mention that, 
in order to simulate the scattering curves, we had to consider an asymmetric size distribution 
function (Schultz distribution) with quite high polydispersity, i.e. 0.6 and 1.0 for the core and 
the core-shell particles respectively). These finding are in a good agreement with our 
observations from TEM images.  
Although there are many contradictory findings reporting toxicity of silver NPs, literature 
reveal that its cytotoxicity mainly depends on the release of Ag+ ions and ROS generation22. 
Since it has been shown that release of Ag+ ions is the main toxicity mechanism on human cells 
23, it was tried to synthesize a tight shell of ZnO to minimize or eliminate release of Ag+ ions , 
in addition to enhancing the photocatalytic properties of Ag@ZnO NPs 24. So, characterization 
of Ag+ release is critical for understanding the environmental fate, toxicity, and biomedical 
impacts of Ag NPs. In these regards, release of silver ion from Ag@ZnO NPs was evaluated 
every 5 days for a total of 75 days and the results were compared with that of Ag NPs. Obtained 
results did not show any significant release of Ag+ ions form Ag@ZnO NPs, while 70% of 
silver was released from Ag NPs, as illustrated in Figure 2G. Reports indicate that surface 
coating significantly determines Ag+ ions related-process kinetics in Ag NPs 25. A previous 
report demonstrated that 16%-20% Ag+ ions was released from PVP/ PEG-coated Ag NPs after 
2 h, while the release of Ag+ ions for gelatin, citrate and chitosan coated Ag NPs was about 1-
3% for 2 h. Thus, the role of polymer coating in controlling the release appears to be minor, 
acting as a reservoir of Ag+ which may subsequently be released 26. Furthermore, polymers 
may quench generation of ROS from silver NPs and decrease the anticancer efficiency of Ag 
NPs 27. Results of our research indicate that Ag@ZnO NPs remained stable for 75 days without 
any significant Ag+ release. It seems that the tight-crystal structure of ZnO shell could 
completely prevent release of Ag+ ions from Ag@ZnO NPs.  
 
Figure 2. Schematic illustration of Ag@ZnO NPs synthesis procedure (A). Transmission 
Electron micrograph (TEM) of Ag@ZnO NPs (B) and corresponding size distribution analysis 
(C). UV-Vis spectra of Ag NPs, ZnO NPs and Ag@ZnO NPs (D). X-ray diffraction 
Spectroscopy (XRD) of ZnO and Ag@ZnO NPs (E). The experimental small angle scattering 
from Ag nanoparticles and the Ag@ZnO core-shell nanoparticles (open circles) together with 
the corresponding simulated curves (solid lines). The polydispersity parameters of 0.6 and 1 
with a Schultz distribution function were used for Ag NPs and Ag@ZnO NPs, respectively (F). 
ICP-MS results for Ag+ ions release studies during 75 days, evaluated every 5 days in water 
solutions (G)  
 
Uptake of Ag@ZnO NPs by Cells 
Inverted confocal microscopy was applied to evaluate cellular uptake of Ag@ZnO NPs in 
MDA-MB231 and MRC-5 cells. Also, in order to confirm the presence of fluorescent dye on 
the surface of prepared RhB-labeled Ag@ZnO NPs, they were characterized by UV-Vis 
spectroscopy as well as zeta sizer. Results of zeta potential measurement showed that 
conjugation of RhB on the surface of Ag@ZnO NPs reduces electric potential of bare surface 
of the Ag@ZnO NPs (Figure 3B). Interaction between surface atoms and the dye can result in 
modification of surface charge, thereby changes the zeta potential 28. 
Moreover, obtained results for UV-Vis absorbance spectra indicates that Rh-B is bonded to the 
surface of NPs (Figure 3C) 29. The spectrum exhibits an excitonic absorption peak at about 
320 nm for free Ag@ZnO NPs and a single peak for RhB dye at 580 nm. In case of RhB labeled 
Ag@ZnO NPs, both peaks of NP and dye are noticeable due to a successful attachment of dye 
to NPs 30. Additionally, labeling of Ag@ZnO NPs by Rh-B causes a small red shift in 
absorption peak (350 nm) of Ag@ZnO NPs. Obtained results of confocal microscopy studies 
showed that Ag@ZnO NPs are taken up by the cells efficiently after 2 h incubation (Figure 3 
D, E and S4). Results show that 94% of cancer cells have taken up substantial amounts of 
Ag@ZnO NPs after 2 h of incubation, while results of NPs uptake by healthy cells showed a 
78% NP uptake (Figure S5), which is comparable to previous report for ZnO NPs 13. The red 
fluorescence of internalized Rh-B in extra nuclear region of the treated cells, clearly illustrates 
that the Ag@ZnO NPs could be internalized into the cancer cells (Figure 3E). Recent studies 
have shown that ZnO NPs have high affinities to cancer cells 31. Also, They have different 
cytotoxicity profiles due to different cell uptake and cytotoxicity pathways 32. Considering size 
as only determinant factor for nanoparticle uptake, it could be suggested that the Ag@ZnO NPs 
have the best potent size for cancer cell’s internalization which was reported about 50 nm 33. 
The DLS study of Ag@ZnO NPs dispersed in cell media showed a mean diameter of 70 nm. 
Since, it has been reported that 120 nm NPs are taken up through clathrin-mediated endocytosis 
and 50-80 nm NPs are mainly internalized by caveoline mediated endocytosis, the synthesized 
NPs have potential to uptake by endocytosis 34.  
 
In-Vitro Toxicity Evaluation of Ag@ZnO NPs on Breast Cancer Cells 
Low cytotoxicity of nanoparticles on healthy cells is a main condition for their biomedical 
applications. Toxic effects of Ag NPs, ZnO NPs and Ag@ZnO NPs on healthy lung fibroblast 
(MRC-5) and breast cancer (MDA-MB231) were assessed by MTT and LDH assays in dark 
and under UV radiation (Figure 4 A, B).  
 
 
Figure 3. Schematic illustration of Rh-B conjugated Ag@ZnO NPs (A), Zeta potential 
evaluation of bare NPs and Rh-B conjugated NPs (B). UV-Vis spectra of Free Ag@ZnO NPs, 
Rh-B and Rh-B conjugated Ag@ZnO NPs (C), Representative corresponding laser confocal 
micrograph images of MRC-5 cells (D) and MDA-MB231 (E) incubated with Rh-B labelled 
Ag@ZnO NPs for 2 hours. Scale bar: 20 μm. 
 
MTT Results in dark conditions revealed a dose-dependent cytotoxicity for all types of NPs. 
However, the cytotoxicity of Ag NPs is significantly higher than the other two groups. Cell 
lines treated with ZnO NPs and Ag@ZnO NPs, in dark condition, remained more than 70% 
viable at concentration 20 µg/ml (Figure 4A). The findings reveal that ZnO NPs and Ag@ZnO 
NPs do not have any considerable cytotoxicity in cancerous and healthy cell lines in absence 
of excitation radiation. A previous research showed that naturally abundance of Zn+ ions in the 
human body results in low toxicity of ZnO NPs which makes it a suitable nanoparticle in 
biomedical applications 35. In Ag@ZnO NP, ZnO shell prevents the release of Ag+ ions and 
decreases the cytotoxicity of Ag@ZnO NPs. A previous research showed that decrease of 
dissolution rate and amount of Ag+ ions after coating with PVP resulted in decrease in 
cytotoxicity of Ag NPs 36. Also, results of toxicity studies demonstrate that viability of healthy 
cells is generally more than the cancerous cells after treatment with NPs. The results indicate 
that  healthy cells are able to tolerate mild oxidative stress due to higher antioxidant 
capacities37,38. 
Results of the MTT assays under UV radiation have also shown a concentration-dependence 
reduction in cell viability of NPs-treated cell lines (Figure 4B). From the details, ZnO NPs 
show concentration-dependent toxicity under UV radiation in cancer cells, although with less 
intense effect in comparison with Ag@ZnO NPs (Figure 4B). The cytotoxicity of Ag@ZnO 
NPs and ZnO NPs significantly increased (80% at 30 µg/ml concentration of Ag@ZnO and 
65% for ZnO NPs) in presence of UV radiation exposure (Figure 4B). These excellent 
photocatalytic performances of ZnO NPs have been illustrated in previous observations (35, 
36). Also, our results showed that Ag NPs under UV radiation have nearly similar toxic effects 
with dark condition on both cell lines. The research demonstrated that the main toxicity 
mechanisms of Ag NPs are due to release of Ag+ ions which act as a Trojan horse, entering 
cells 39, a mechanism which is independent of radiation. 
Internalization of NPs and consequent cytotoxicity are associated with release of LDH due to 
cell membrane disruption. Evaluation of LDH release showed that ZnO NPs and Ag@ZnO 
NPs cause ̴ 20% LDH release at the highest concentration (30 µg/ml) in dark conditions, while 
this value is about 80% for Ag NPs at same concentration (Figure 4C). This results is in 
agreement with previous studies 40. More importantly, treatment of cells with Ag@ZnO NPs 
under UV radiation significantly increases the release of LDH up to 97% in cancer cells 
compared with 60% for healthy cells at 30 µg/ml concentration, probably due to enhanced ROS 
generation in comparison with ZnO NPs. The results of LDH release indicate that antioxidant 
capacity of healthy cells are sufficient for protection against high amount of ROS 41. Also, ZnO 
NPs have shown 65% LDH release in both cell lines, under UV radiation (Figure 4D). 
Furthermore, when comparing UV and dark condition, Ag NPs have similar toxic patterns. In 
total, results show that Ag@ZnO NPs are highly toxic under UV radiation, they are not 
considerably cytotoxic in dark conditions. Previous investigation has shown that coating of 
biogenic silver NPs by ZnO shell, has improved the anti-fungal properties of silver NPs without 
any significant toxicity on healthy cells 42. Although, this report did not consider the effect of 
Ag@ZnO NPs as a photocatalyst nanomaterial, biocompatibility of synthesized NPs in dark 
condition was shown to improve. So, these properties could make them a perfect choice in 
targeted photodynamic therapy of cancer cells.  
 
 
Figure 4. toxicity assessment of MRC-5 as healthy cells and MDA-MB231 as cancerous cells 
after treatment with different concentrations of Ag NPs, ZnO NPs and Ag@ZnO NPs in dark 
condition and under UV radiation. MTT assays (A, B), LDH Assays (C, D). All data were 
compared with control and the line means they are same significance.  
 
Intracellular ROS-Dependent Cytotoxicity of Ag@ZnO NPs 
Ag@ZnO NPs have a high potential to generate radicals due to direct contact of ZnO and Ag 
which results in interfacial processes of charge transfer when radiated by an external UV. 
Increased photocatalytic activity of Ag@ZnO NPs has previously been reported as solar 
photocatalytic disinfection process 21, 43. Also, reports showed that induction of high amount of 
ROS, could remarkably overwhelm the antioxidant capacity of the cells and cause cell death 
44.  
So, inspired by previous works, in this research, ROS generation was measured by 
neutralization of DPPH as a stable radical. Results of DPPH assay showed that ZnO NPs and 
Ag@ZnO NPs generate high amount of ROS in a concentration dependent manner after 
exposure to UV radiation. Figure 5A shows that ZnO and Ag@ZnO NPs generate different 
amounts of ROS under UV radiation as discussed before. This consequence is particularly more 
obvious for Ag@ZnO NPs due to a higher photocatalytic activity. Previous reports have shown 
that ZnO NPs can produce ROS after stimulation by UV light 45. Even though Ag NPs provided 
a strong toxicity profile in dark and under UV radiation on healthy and cancer cells, their ROS 
generation are less than the other NPs. This confirms that the main toxicity mechanism of Ag 
NPs is not ROS generation, but most probably release of Ag+ ions 46. Moreover, the high 
toxicity of Ag@ZnO NPs under UV radiation is dependent on ROS generation while these NPs 
are not toxic for cells in dark condition. Ag@ZnO NPs are able to generate free radicals during 
interaction with cellular components (e.g., mitochondrial damage, Bax/Bcl2 modulation, 
caspases activation and apoptosis) 47. The produced radicals can oxidize or reduce the DNA, 
lipids and proteins and other important biological components, resulting in substantial 
oxidative damages to the cell. In this regard, flow cytometry was employed to evaluate different 
types of intracellular radicals for synthesized NPs under UV radiation (Figure 5B, C).  The 
results of intracellular ROS in ZnO NPs and Ag@ZnO NPs-treated cells under UV radiation 
demonstrated an increase in fluorescence intensity of DCF and HE as markers of H2O2 and O2 
radicals in comparison with dark conditions (Figure 5B). From the details, Ag@ZnO NPs 
generated higher levels of H2O2 radicals associated with permanent photoactive holes on the 
surface 48. These holes form spatially indirect excitons in the interface of Ag/ZnO which 
transfer to surface of NPs after UV excitation and result in a high amount of electron capture 
from environmental molecules and consequent H2O2 
49. Ag@ZnO NPs has been reported as a 
high photocatalyst nanomaterial in catalysis applications and electronic procedures 15, 19. 
Moreover, obtained results for ROS generation in dark condition (Figure 5B and S6), show no 
significant radical production for ZnO NPs and Ag@ZnO NPs-treated cells in comparison with 
untreated ones. Also, the estimated results for ROS generation suggest that Ag NPs induce 
medium levels of H2O2 and O2 radicals in comparison with ZnO NPs and Ag@ZnO NPs. 
Furthermore, Ag@ZnO NPs-mediated intracellular ROS generation was determined by DCF 
fluorescence microscopy assay in MDA-MB 231 and MRC-5 cells (Figure 5C). The ROS-
generation capability of Ag@ZnO NPs may lead to various pathways in cells which results in 
mutations and oxidative damage of cells50-51. Also, researcher reported that ZnO NPs induce 
oxidative stress, with significant formation of reactive oxygen species (ROS) inside the cells 





Figure 5. ROS generation ability of NPs in solution assessed with DPPH (A), Representative 
flow cytometry marker (B) for Ag NPs, ZnO NPs and Ag@ZnO NPs treated MDA-MB231 
cells in dark condition and under UV radiation. Positive DCF fluorescence represents 
intracellular H2O2 and positive HE fluorescence represents intracellular O2
·. Representative 
microphotographs shows confocal study of intracellular ROS generation of Ag@ZnO NPs after 
UV radiation measured by DCF fluorescent in MDA-MB231 and MRC-5 Cells (C), Scale bar: 
10 μm. 
 
Glutathione reductase and superoxide dismutase are recognized as the most important cellular 
antioxidant enzymes in modulation, regulation  and maintenance of cellular oxidative stress 
response as well as redox homoeostasis 53. Hence, to investigate the potential role of oxidative 
stress, activity of the mentioned enzymes was monitored after treating cells with different 
concentrations of Ag NPs, ZnO NPs and Ag@ZnO NPs, in dark condition and under UV 
radiation (Figure 6). Although, ZnO NPs and Ag@ZnO NPs in dark condition did not show 
any significant effect on increase of cellular antioxidant enzymes, Ag NPs significantly 
increased the amount of glutathione reductase as well as superoxide dismutase enzymes (Figure 
6 A, B). Increase in enzymes activity is due to intracellular ROS generation of Ag NPs in dark 
condition as shown by flow cytometry results. Previous reports showed that treatment of rat 
liver cells with Ag NPs reduced glutathione levels, and raised ROS production, representing 
effect of metal NPs on respiratory chain. Also, generated ROS in presence of Ag NPs causes 
metabolic disturbances and toxicological consequences 54. Subsequently, increase in oxidative 
stress levels results in enhancement of glutathione reductase and superoxide dismutase. After 
UV exposure to Ag@ZnO NPs, increased levels of superoxide dismutase (10-fold) and 
glutathione reductase (2-fold) in comparison with controls were observed. Generated oxidative 
stress by Ag@ZnO NPs under UV radiation as a mechanism of toxicity results in shift of 
overall redox balance to oxidation which leads to functional damage of cells 55 (Figure 6C). 
 
 
Figure 6. Antioxidant response of  NPs–treated MDA-MB231 and MRC-5 cells in dark 
condition and under UV radiation, concentration of Gluthation reductase (A) and Superoxide 
dismutase (B) after treatment.  (C) Schematic represents the cell’s oxidative stress responses 
initiate by superoxide dismutase (SOD), glutathion reductase (GR) and glutathion peroxidase 
(GPx) in cells after treatment with Ag@ZnO NPs under UV radiation. The background shows 
the interacellular DCF green fluorescence as an indicator of ROS generation along with red 
colored MD-MB 231 nucleus after treatment with Ag@ZnO NPs which were captured by 
confocal microscopy.    
 
Distinct Cellular Fates (Apoptosis and Related-Enzymatic Cascade) 
To investigate mechanism of MDA-MB231 cell death induced by Ag@ZnO NPs, AnnexinV-
PI assay was used for different concentrations. Obtained results for highest concentration of 
Ag@ZnO NPs-treated MDA-MB231 cells in dark condition showed 17.9% apoptosis and 5.1% 
necrosis which is consistent with cytotoxicity assays (Figure 7A). The results showed 20% cell 
death during treatment in dark condition. However, Results of UV treatment demonstrated that 
the main cause of cell death is apoptosis, about 31% of the cells were positive for necrosis/late 
apoptosis (Detailed in Figure S7). The enhanced concentration-dependent apoptosis of 
Ag@ZnO NPs indicates an exclusive role for ROS in killing cancerous cells56. Participation of 
ROS was shown by a strong positive association between ROS generation and early apoptosis 
(Figure S7). It has also been demonstrated that induced apoptosis by Ag NPs is mediated by 
oxidative stress in fibroblast, colon and lung cancer cell lines 55, 57. 
Reports indicated that the oxidative stress is directly involved in DNA damage and causes 
intrinsic mitochondria-dependent apoptosis cascade. So, in this study, levels of key apoptotic 
cascade proteins (caspase 3, Bax/Bcl2, cytochrome C and P53) were measured in cells treated 
with NPs for 6 h. Among these,  B-cell lymphoma 2 (Bcl-2) family controls outer mitochondrial 
membrane permeabilization and can apply pro-apoptotic (bax, bad, bak) effects by activation 
of an inner mitochondrial permeability transition pore58-59. Obtained results of Bax/Bcl2 studies 
showed no significant difference in enhancement of Bax/Bcl2 for cells treated with ZnO NPs 
and Ag@ZnO NPs in dark condition, whereas Ag NPs enhanced Bax expression and decreased 
bcl2 (Figure 7B). The changes after Ag treatment may occur due to either release of Ag+ ions 
or ROS generation in dark condition. Moreover, the results for MDA-MB231 cells after 
treatment with Ag@ZnO NPs under UV radiation showed modulation of Bax and Bcl2 protein 
levels with a significant increase in Bax expression and a parallel/corresponding decrease in 
Bcl2. These Bcl2 proteins play important role in mediated apoptosis by mitochondrial pathway 
which results in release of activated pro-apoptotic factors by caspase cascade 47.  
Clearly, most of the chemotherapeutic drugs trigger the apoptosis through activation of p53 
pathway. So, in this work, the effect of Ag@ZnO NP on p53 protein expression was determined 
using the enzyme-linked assay method. Herein, an up-regulation of p53 (2.5 folds) was 
observed at highest conncentration of Ag@ZnO NPs under UV radiation (Figure 7C). Results 
showed a significant difference in p53 expression between controls and cells treated with 20 
and 30 μg/ml of Ag@ZnO NPs under UV radiation. Although,  ZnO NPs and Ag@ZnO NPs 
did not show any significant increase in p53 in dark condition, Ag NPs showed increase in p53 
amount in both dark and UV radiation. It has already been described that Bax protein is up-
regulated by p53 protein 57. Since an enhancement in Bax expression in cells treated with 
Ag@ZnO NP was observed, the role of p53 in up-regulation of Bax can be confirmed. 
Moreover, insertion of Bax into the mitochondrial membrane feasibly results in p53-mediated 
apoptosis 60. Similar results showed that p53 plays an important role in Ag NP-induced 
apoptosis as a conseguence of interacellular ROS generation 61 . After treatment of MDA-
MB231 cells with Ag@ZnO NPs under UV radiation, protein expression of cell cycle 
checkpoint p53 and pro-apoptotic bax were up-regulated, while expression of Bcl-2 as an anti-
apoptotic gene was down-regulated, in comparison with control groups 59. 
Furthermore, release of cytochrome C is an improtant marker for mitochondria-mediated 
apoptosis. MDA-MB231 cells treated with Ag@ZnO NPs, demonstrated an increase in release 
of cytochrome C release in a concentration-dependent manner under UV radiation. The results 
for ZnO NPs and Ag@ZnO NPs-treated cells in dark condition have not shown any significant 
cytochrome release, wherese Ag NPs caused significant enhancement in release of cytochrom 
C in dark condition as well as UV radiation (Figure 7D). Also, leakage of cytochrome C from 
the mitochondria into the cytoplasm, triggers ROS pruduction and depletion of cellular 
glutathione which are related to apoptosis. Cytochrome C binds to apoptosis protease activating 
factor-1 (Apaf-1) which results in assembly of an apoptosome compound. The apoptosome 
could activate caspase-3, which cleaves substrates of aspartate residues and consequently leads 
to activation of proteolytics as an event in apoptosis 62.  
Moreover, caspase3 is activated during apoptosis which is known as a vital protein in initiation/ 
execution of apoptosis. ROS is another factor that triggers the apoptotic cascade 63. In this 
context, activation of caspase-3 is considered as a point with no return in apoptosis pathway 64. 
Caspase-3 activation causes cleavage of ICAD (inhibitor of caspase-activated DNAse) and 
translocation of CAD (caspase-activated DNAse) to the nucleus which results in DNA 
fragmentation 55. DNA cleavage is the most noticeable event in early stages of apoptosis 65. 
Also, caspase-3 is identified as ultimate responsible factor for apoptosome formation, in 
caspase-dependent pathway of apoptosis. The results showed higher activity (2.5 fold) of 
caspase-3 in cells treated with  30 µg/ml of Ag@ZnO NPs under UV radiation, in comparison 
with controls (Figure 7E).  
Our apoptotic data supported the ROS-induced cytotoxicity of Ag@ZnO NPs which causes 
higher apoptotic response than Ag NPs and ZnO NPs under UV radiation. Previous reports 
explained that toxicity of ZnO NPs is due to dissolution of the particles into Zn2+ ions 66. 
However, some investigations state that the amount of released Zn2+ ions in aqueous medium, 
are insufficient to stimulate cytotoxicity in human cells67. The schematic in Figure 7F 
represents the involved proteins in apoptotic pathway which starts with Ag@ZnO NPs as a 
consequence of ROS generation. Furthermore, All experiments were performed for healthy 
cells as well, and showed that the importance of the protein expression after oxidative stress is 
to some extent similar in healthy and cancerous cells.  
 
Figure 7. Flowcytometry results of control in comparison with Ag@ZnO NPs treated cells in 
dark condition and under UV radiation (A). Release of Bax/Bcl2 in Ag@ZnO NPs treated cells 
(B). Evaluation of protein changes of cells after treatment with Ag@ZnO NPs; P53 (C), 
Release of Cytchrome C (D) and caspase 3 activity (E) in dark condition and under UV 
radiation. Schematic represents the apoptosis mechanisems which triggers by Ag@ZnO NPs.  
The uptaken NPs, generate ROS after excitation with UV radiation which are triggered 
activation of p53 protein. In turn, p53, a known activator of pro-apoptotic genes, activates bax 
and decrease the amount of bcl2. These proteins cause mitochondrial membrane leakage 
subsequence cytochrome C release, which activates caspase-3 in the apoptotic cascade. 
Eventually, caspase-3 induces DNA fragmentation with cleavage of nuclear membrane and 
causes apoptosis (F).  
CT/ Optical dual contrast enhancement of Ag@ZnO NPs 
To evaluate possible diagnostic application of Ag@ZnO NPs, the synthesized NPs were 
examined as CT/optical imaging contrast agents, followed by photo luminescence (PL) spectra 
evaluation. 
In this regard, capability of Ag@ZnO NPs as CT contrast agents were examined by applying 
a 16 slice clinical CT imaging system. In order to evaluate the efficiency of synthesized NPs 
as CT contrast agent, their X-ray attenuation ability was compared with Visipaque®, the widely 
used CT contrast agent in clinical imaging. Obtained results showed an enhancement in 
contrast and brightness of CT images for Ag NPs and Ag@ZnO NPs, in comparison with water 
as control negative (Figure 8). Moreover, Ag@ZnO NPs showed an extensive enhancement in 
image contrast at concentrations of 0.08 mM compared with conventionally used contrast agent 
(i.e. Visipaque® at 225 mM concentration). Therefore, it is arguable that ZnO NPs protection 
layer in Ag@ZnO NPs, makes the NPs stable and safe contrast agents for CT tomography. 
Additionally, core structure of Ag@ZnO NPs makes them potential agents for X-ray computed 
tomography with lower concentration, in comparison with iodine-based molecular CT contrast 
agents. The lower concentration could considerably reduce side effects of the contrast agents 
68. Previous reports have shown that high atomic number elements, like lanthanides doped in 
ZnO crystal 13, Gd-coated/conjugated Au NPs 69 , Ag NPs with different sizes 70 and  Au‐Fe 
alloy nanoparticles 71 could potentially enhance the contrast of CT images. Using high atomic 
number elements in structure of NPs, makes them capable of being traced in CT imaging at 
potentially safe concentrations. 
Figure 8A shows the PL spectra of Ag@ZnO NPs in ambient temperature which comprises 
two emission bands in the UV/visible region with 325 nm excitation wavelength. Obtained 
graph shows an intense narrow emission peak in UV range centered at 380 nm for ZnO without 
any specific position changes after adding Ag NPs as core in Ag@ZnO NPs. Normally, this 
emission is assigned to the excitonic recombination in ZnO NPs 72. Also, lower intensity 
emission band centered at 320 nm is related to exciton recombination of Ag and ZnO interfaces 
which comes from some border traps of radiative defects between Ag and ZnO 73. After 
addition of ZnO as shell, PL intensity in ultraviolet is practically quenched due to the charge 
transfer from ZnO to Ag, which provides perfect evidence that the semiconductor-metal contact 
increases the photo activity of core/shell structure. In addition, The Ag@ZnO NPs showed a 
wider peak in the visible region, centered at 580 nm (i.e. 520-650) with lower intensity in 
comparison with pure ZnO NPs. These multicomponent wide visible emission spectra in ZnO 
are related to some intrinsic and extrinsic defects which encompass the orange/red fluorescent 
region 74.  
In this regard, the results for optical images demonstrated an orange, red fluorescent color for 
ZnO NPs and Ag@ZnO NPs, respectively. The fluorescent color of images converted brighter, 
corresponding to the rise in concentrations. Even though these NPs are not applicable for 
conventional confocal study, due to excitation limitation of lasers, obtained results showed that 
Ag@ZnO NPs could serve as effective optical imaging contrast agents. literature shows that 
the non-centrosymmetric structure of ZnO NPs can be used as non-resonant/ non-linear optical 
probe for biomedical applications 75. Also, previous reports demonstrate the application of rare 
earth element-doped nanocrystals as fluorescent probes for cathodoluminescence electron 
microscopy bio-imaging 76. Overly, these specific structures consist of high atomic number 
elements in core as well as photoactive ZnO as shell, make the NPs capable to be traced in 


















Figure 8. PL luminescence spectrum of Ag, ZnO and Ag@ZnO NPs (A). 16 slice clinical-CT 
tomograph of synthesized NPs with different concentrations in comparison with water and 
Visipaque®. Signal strength is indicated by the brightness of the images (B, left), optical 




We found that Ag@ZnO NPs as novel nanocomposite structure, improve the characteristic 
photoactivity of ZnO NPs under UV radiation on treatment of human breast cancer cells while 
represent minimum toxicity in dark conditions. The improved photocatalytic activity of 
Ag@ZnO NPs is related to charge transfer in metal/semiconductor interfaces. Moreover, 
A 
B 
enhanced ROS generation and photocatalytic activity of Ag@ZnO NPs, trigger apoptosis 
related pathway in breast cancer cells through activation of tumor suppressor gene p53 and 
along with cytochrome C and caspase-3 proteins. Also, Increase in Bax/Bcl2 ratio suggests that 
Ag@ZnO NPs prompt apoptosis through mitochondrial pathway. Furthermore, Ag@ZnO NPs 
showed the capability to be assisted in multimodal detection by CT/optical imaging. Based on 
results, Ag@ZnO NPs are potentially applicable for simultaneous imaging and therapy as 
targeted photosensitizer in photodynamic therapy.  
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